CLINICAL_TRIALS
trial_result
· 2016-12-13
Clinical Trial Update: Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis [Phase 3]
Summary
A Phase 3 trial evaluating Apitox (honeybee venom toxin) for pain and inflammation in knee osteoarthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Apimeds, Inc. | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED